Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
Anticoagulants
|
tPA, heparin, PGI2, ATIII (antithrombin) protein C/S
|
|
Heparin
|
Enhances antithrombin activity (neutralizes all factors except V, VIII, fibrinogen)
|
|
Prostein C/S
|
Neutralize V and VIII
|
|
Von Willebrand Factor
|
Complexes with factor VIII to enhance VIII: C activity; platelet adhesion
|
|
Platelets
|
Receptor for von willebrand factor and fibrinogen; syntheize TXA2
|
|
GPIb
|
Platelet receptor for vWF
|
|
GpIIb/IIIa
|
Platelet receptor for ribrinogen
|
|
Extrinsic system factor
|
VII
|
|
Intrinsic System Factors
|
XII, XI, IX, VIII
|
|
Final common pathway factors
|
X, I, prothrombin (II), fibrinogen (I)
|
|
Factor XIII
|
Cross links insoluble fibrin; strengthens fibrin clots
|
|
Vitamin K dependent factors
|
Prothrombin (II), VII, IX, X, Protein C/S
|
|
Factors consumed in a clot
|
Fibrinogen, prothrombin, V, VIII, fluid is called serum
|
|
Plasmin
|
Cleaves fibrinogen and insoluble fibrin into degradation products
|
|
Bleeding time
|
Evaluates platelet function (adhesion, release reaction, aggregation)
|
|
Asprin
|
MCC of a prolonged bleeding time
|
|
PT
|
Evaluates extrinsic pathway to fibrin clot
|
|
PTT
|
Evaluates intrinsic pathway to stable fibrin clot
|
|
Fibrinolysis tests
|
Degradation prodcuts, D-dimers (cross linked insoluble fibrin)
|
|
S/S platelet dysfunction
|
Cannot form temporary plug; epistaxis; petechiae; bleeding from scratches
|
|
Idiopathic thrombocytopenic purpura (ITP)
|
Children; antibodies against GpIIb: IIIa; no splenomegaly
|
|
Chronic Autoimmune Thrombocytopenic Purpura
|
SLE; antibodies against GpIIb: IIIa receptors
|
|
Heparin
|
Thrombocytopenia due to IgG antibody against heparin attached to PF4 on platelets
|
|
PF4
|
Heparin neutralizing factor
|
|
HIV
|
Thrombocytopenia MC hematologic abnormality; similar to ITP
|
|
Thrombotic Thrombocytopenic Purpura
|
Platelet thrombi develop in areas of endothelial damage in small vessels; consumption of platelets
|
|
S/S TTP
|
Fever, thrombocytopenia, renal failure, hemolytic anemia with schistocytes, CNS deficits
|
|
Findings TTP
|
Thrombocytopenia, prolonged bleeding time, normal PT an dPTT
|
|
HUS
|
Similar to TTP; endothelial injury from Shiga like toxin of ETEC in undercooked beef
|
|
S/S Factor Deficiency
|
No stable fibrin clot; late rebleeding; menorrhagia; GI bleeding
|
|
Hemophilia A
|
XR; hemarthroses; prolonged PTT; Decreased factor VIII activity
|
|
Von wIllebrand's disease
|
platelet adhesion defect + factor VIII deficiency
|
|
Lab findings in vWD
|
Decreased vWF, VIII antige and VIII: C prolonged bleeding time
|
|
Vitamin K Deficiency
|
Decreased epoxide reductase activity (decreased function vitamin K); hemorrhagic diathesis; increased PT
|
|
Causes vitamin K deficiency
|
Antibiotics MC, newborn, malabsorption, warfarin
|
|
DIC
|
Activation coagulation system from release of tissue thromboplastin and/or endothelial cell damage
Consumption coagulation factors by fibrin clots; pt also anticoagulated |
|
Causes DIC
|
Septic shock MCC; rattlesnake bite, massive trauma, amniotic fluid
|
|
Lab findings DIC
|
Thrombocytopenia; increased PT and PTT, D-dimers (beta test), anemia
|
|
Warfarin
|
Inhibits epoxide reductase, PT best test but PTT also prolonged
Full anticoagulation in three days when prothrombin dissappears |
|
Rx Warfarin Overcoagulation
|
Intramuscular vitamin K, fresh frozen plasma (immediate)
|
|
Hemophilia A
|
XR; hemarthroses; prolonged PTT; Decreased factor VIII activity
|
|
Von wIllebrand's disease
|
platelet adhesion defect + factor VIII deficiency
|
|
Lab findings in vWD
|
Decreased vWF, VIII antige and VIII: C prolonged bleeding time
|
|
Vitamin K Deficiency
|
Decreased epoxide reductase activity (decreased function vitamin K); hemorrhagic diathesis; increased PT
|
|
Causes vitamin K deficiency
|
Antibiotics MC, newborn, malabsorption, warfarin
|
|
DIC
|
Activation coagulation system from release of tissue thromboplastin and/or endothelial cell damage
Consumption coagulation factors by fibrin clots; pt also anticoagulated |
|
Causes DIC
|
Septic shock MCC; rattlesnake bite, massive trauma, amniotic fluid
|
|
Lab findings DIC
|
Thrombocytopenia; increased PT and PTT, D-dimers (beta test), anemia
|
|
Warfarin
|
Inhibits epoxide reductase, PT best test but PTT also prolonged
Full anticoagulation in three days when prothrombin dissappears |
|
Rx Warfarin Overcoagulation
|
Intramuscular vitamin K, fresh frozen plasma (immediate)
|
|
Heparin
|
Enhances antithrombin; PTT best test but PT also prolonged
|
|
Factor V Leiden
|
MC hereditary thrombosis; resistant to degradation by protein C/S
|
|
ATIII Deficiency
|
No prolongation of PTT with administration of heparin
|
|
M Cells
|
Specialized cells that transfer foreign antigens to lymphocyte sin Peyer's patches
|
|
Blood group O
|
Anti-AB-IG antibodies; increased incidence of duodenal ulcers
|
|
Newborns blood typing
|
do not have natural blood group antibodie at birth
|
|
Elderly blood typing
|
May lose natural blood group antibodies; no hemolytic reaction to mismatched blood
|
|
Duffy Antigen
|
Receptor for plasmodium vivax; blacks often lack Duffy antigen
|
|
Antibody Screening
|
Indirect Coomb's test; detects atypical antibodies in serum
|
|
Hepatitis C is most common caused by what
|
MCC of post transfusion hepatitis
|
|
Universal Donor
|
Blood group O; no antigens on surface of RBCs
|
|
Universal recipient
|
Blood group AB; no natural blood group antibodies in serum
|
|
Fresh frozen plasma
|
Replacement for multiple factor deficiencies (cirrhosis, DIC)
|
|
Rh Hemolytic Disease of Newborn
|
mother Rh (D antigen) negative and fetus Rh (D antigen) positive
no hemolysis in first Rh incompatible pregnancy materal anti-D crosses placenta in second pregnancy; potential for hydrops fetalis; high risk for kernicterus |
|
Rh immune globulin
|
anti-D; coasts D antigen site on fetal RBCs in maternal circulation
|
|
Rh HDN lab
|
positive direct Coomb's test; severe anemia and hyperbilirubienmia
|
|
Phototherapy (blue fluoresent light)
|
Converts unconjugated bilirubin in skin into harmless water soluble dipyrrole
|